Cresco Labs Inc

The Analyst Following Cresco Labs’ (OTC: CRLBF) (CSE:CL) conference call, Pablo Zuanic,  from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19. “We will not update forward quarterly estimates until SEDAR is out (expected tomorrow...

The Analyst Pablo Zuanic, from Cantor Fitzgerald, rated Columbia Care Inc. (OTC: CCHWF) as Overweight with a price target of $5.10. The Thesis Columbia Care reported its unaudited financial and operating results for the first quarter ended March 31, 2022, on Monday. The firm reported revenue of $...

There are several key parameters an investor should consider when investing in the cannabis space, according to Entourage Effect Capital (EEC) Managing Director Codie Sanchez. Most of the market is currently small- to mid-cap, and any cannabis stock could be a worthwhile investment...